Report #21-E-0043, December 29, 2020. In response to the CSB’s request, the OIG for the U.S. EPA—which also serves as the OIG for the CSB—completed an evaluation of the CSB’s compliance with Executive Order 13950, Combating Race and Sex Stereotyping.
Report #21-E-0016, November 18, 2020. The CSB was at risk of not being able to readily restore information technology operations if they were disrupted during the coronavirus pandemic.
Report #21-F-0015, November 16, 2020. The CSB received an unmodified opinion on its fiscal years 2020 and 2019 financial statements.
Report #20-N-0218, July 6, 2020. Unaddressed management challenges will impede the ability of the CSB to function effectively.
Report #20-P-0077, February 12, 2020. The CSB lacks documented procedures to address information technology risks and threats from cybersecurity incidents.
Report #19-P-0147, May 9, 2019. The CSB lacks established procedures for automated processes and authentication technologies, which could permit unauthorized access to agency systems.
Report #2007-S-00001, June 4, 2007. CSB did not adhere to its Merit Promotion Plan during the process under which it reassigned three investigators to supervisory positions.
Report #20-N-0064, Jan 23, 2020. We found that the CSB was fully compliant with improper payments legislation and guidance during fiscal year 2019.
Report #20-F-0032, November 19, 2019. The CSB received an unmodified opinion on its fiscal years 2019 and 2018 financial statements.
Report #19-P-0245, July 26, 2019. The Chemical Safety Board (CSB) purchase card program, through which the agency spent $326,859 in FY 2018, is at low risk for unauthorized purchases.
Report #19-N-0156, May 20, 2019. The CSB faces two challenges in FY 2019 that, if not addressed, may impede its ability to efficiently and effectively achieve its mission or meet its goals.
Report #19-N-0070, February 12, 2019. Pursuant to our role under the Improper Payments Elimination and Recovery Act (IPERA) of 2010, we reviewed the CSB's compliance for fiscal year 2018 with improper payments legislation and guidance.
Report #19-F-0004, November 14, 2018. The CSB received an unmodified opinion on its fiscal years 2018 and 2017 financial statements
Report #18-P-0218, July 3, 2018. The CSB's purchase card program, through which the agency spent $321,241 in FY 2017, is at low risk for unauthorized purchases.
Report #18-N-0208, June 4, 2018. The CSB faces two management challenges that, if not addressed, may seriously impede the agency’s ability to achieve its mission efficiently and effectively.
Report #18-P-0175, May 9, 2018. The CSB is fully compliant with the reporting requirements of improper payments legislation.
Report #18-F-0040, November 15, 2017. The CSB received an unmodified opinion on its fiscal years 2017 and 2016 financial statements.
Report #18-P-0030, October 30, 2017. Weaknesses in the Identity and Access Management and Incident Response metric domains leave the CSB vulnerable to attacks occurring and not being detected in a timely manner.
June 9, 2014. The Office of Inspector General is beginning work to update the fiscal year 2014 list of areas we consider to be the key management challenges confronting the U.S. Chemical Safety and Hazard Investigation Board.
Report #17-N-0342, July 27, 2017. Continued CSB management attention on human resources should help CSB maximize its limited funding.
Report #17-P-0303, July 5, 2017. The Chemical Safety Board's purchase card program, for which it spent $238,390 in FY 2016, is at low risk for unauthorized purchases.
Report #16-N-0221, June 29, 2016. Attention to CSB management challenges could result in stronger results and protection for the public, and increased confidence in management integrity and accountability.
Report #16-N-0018, Oct 22, 2015. Attention to CSB management challenges could result in stronger results and protection for the public, and increased confidence in management integrity and accountability.
The EPA Office of Inspector General is beginning work to update our list of areas we consider to be the key management challenges confronting the Chemical Safety and Hazard Investigation Board.
Report #16-P-0086, January 27, 2016. The effectiveness of the CSB’s information security program is challenged by its lack of personal identity verification cards for logical access, complete system inventory.
Report #16-P-0112, March 24, 2016. By not following Federal Acquisition Regulation requirements, the CSB’s $125,000 Vantage contract was at risk for mismanagement.
Report #16-P-0109, March 23, 2016. The U.S. Chemical Safety and Hazard Investigation Board (CSB) is fully compliant with the reporting requirements of improper payments legislation.
Report #16-P-0179, May 23, 2016. The lack of internal guidance and implementation of controls puts the U.S. Chemical Safety and Hazard Investigation Board's (CSB) $11 million budget at risk.
Report #16-P-0254, August 1, 2016. CSB has one system that contains sensitive PII. Safeguarding such information in the possession of the government and preventing its breach is essential to ensuring CSB retains the trust of the American public.
Report #16-P-0260, August 11, 2016. The Chemical Safety Board has lowered to low risk its purchase card program, for which it spent $302,556 in fiscal year 2015.
Report #17-P-0045, November 14, 2016. More work is needed by CSB to achieve an overall managed and measurable information security program that can effectively manage cybersecurity risks.
Report #17-F-0047, November 15, 2016. The CSB Received an unmodified opinion on its fiscal year 2016 financial statements.
Report #17-P-0123, March 9, 2017. The Chemical Safety Board (CSB) is fully compliant with the reporting requirements of improper payments legislation.
Report #15-P-0007, October 29, 2014. Over $1.9 million in CSB acquisitions are at risk because the Board did not approve the acquisitions.
Report #16-F-0041, November 16, 2015. The CSB received an unmodified opinion on its fiscal year 2015 financial statements.
Report #16-P-0035, November 5, 2015. Ineffective physical and environmental protection controls place CSB’s investigative data at risk of theft, loss or damage.
Report #15-P-0304, September 30, 2015.At a public meeting, CSB passed a motion to terminate five investigations on which it had already spent over $800,000 in taxpayer funds without announcing the planned motion in advance, as required by the Sunshine Act.
Report #15-P-0245, July 31, 2015. CSB's acquisition process is at risk and may have ineffective operations without a strategy to implement controls. Further, CSB has limited evidence it contracted at the best value.
Report #15-N-0171, June 29, 2015. CSB's $280,000 purchase card program for FY 2014 was assessed as high risk for illegal, improper or erroneous purchases and payments.
Report #15-P-0153, May 1, 2015. CSB is fully compliant with the reporting requirements of IPERA.
Report #15-P-0073, February 3, 2015. CSB’s ability to increase its situational awareness and reduce risk exposure is challenged by its lack of a real-time continuous monitoring strategy.
Report #15-1-0022, November 17, 2014. The CSB received an unmodified opinion for its fiscal years 2014 and 2013 financial statements.
Report #14-P-0181, April 10, 2014. The CSB has an information security program in place that is functioning as designed; the CSB takes information security weaknesses seriously.
Report #14-P-0172, April 10, 2014. Risk of improper payments is increased because CSB did not implement the preventative measures required by IPERIA.
Report #14-1-0038, December 16, 2013. The CSB received an unmodified opinion for its fiscal years 2013 and 2012 financial statements.
Report #13-P-0337, July 30, 2013. CSB does not have an effective management system to meet its established performance goal to “conduct incident investigations and safety studies concerning releases of hazardous chemical substances.”
Report #13-P-0307, June 28, 2013. KPMG noted that the CSB has an information security program in place that appears to be functioning as designed.
Report #13-P-0177, March 12, 2013. CSB is fully compliant with the reporting requirements of IPERA, which require all agencies to periodically review all programs and activities that may be susceptible to significant improper payments.
Report #13-P-0128, February 1, 2013. CSB does not have a follow-up process to allow for prompt implementation of agreed-to OIG audit recommendations.
Nov 2012. This CSB Semiannual Report contains the results of our work related to the U.S. Chemical Safety and Hazard Investigation Board (CSB) for the reporting period April 1, 2012, through Sept 30, 2012.